Physician profile
Stacy N Evans
NPI 1538157631
$1,192.28
in general payments reported to CMS, 2019-2025
16 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $36.06 · 2021: $80.97 · 2022: $50.42 · 2023: $358 · 2024: $335 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $208.96 | 2023-2024 | Azstarys, Azstarys |
| Glaxosmithkline, LLC. | $181.18 | 2019-2025 | Bexsero, Menveo, Penmenvy |
| Pfizer INC. | $169.85 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $140.44 | 2021-2025 | Qelbree, Qelbree |
| Sanofi Pasteur INC. | $130.08 | 2021-2025 | |
| Sobi, INC | $68.24 | 2020-2024 | |
| Ironshore Pharmaceuticals INC. | $63.47 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $44.05 | 2024-2025 | Proquad, Gardasil 9, Gardasil |
| Seqirus USA INC | $39.67 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Neos Therapeutics, LP | $30.73 | 2019 | |
| Medline Industries LP | $26.72 | 2023 | |
| Biomerieux INC | $23.30 | 2023 | |
| Genentech USA, INC. | $17.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.10 | 2023 | Flumist Quadrivalent |
| Shire North American Group INC | $16.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.